about
Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation.The efficacy of intravenous ketorolac for pain relief in single-stage adjustable strabismus surgery: a prospective, randomized, placebo-controlled trial.Comparison of pain-relieving effects of fentanyl versus ketorolac after eye amputation surgeryAttitude and perception of patients and health care practitioners toward oral sustained release dosage forms in Palestine.Effect of Intravenous Ketorolac on Postoperative Pain in Mandibular Fracture Surgery; A Randomized, Double-Blind, Placebo-Controlled Trial.Retrospective analysis of perioperative ketorolac and postoperative bleeding in reduction mammoplasty.Ketorolac tromethamine - routes and clinical implications.Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.Microspheres and tablet in capsule system: A novel chronotherapeutic system of ketorolac tromethamine for site and time specific deliverySuprachoroidal injection of ketorolac tromethamine does not cause retinal damage.Enhancement of ketorolac tromethamine permeability through rat skin using penetration enhancers: An ex-vivo study.Pharmacokinetics of intravenous ketorolac in cats undergoing gonadectomy.Ketorolac and Other NSAIDs Increase the Risk of Anastomotic Leakage After Surgery for GEJ Cancers: a Cohort Study of 557 Patients.Comparison of ketorolac 0.45% versus diclofenac 0.1% for macular thickness and volume after uncomplicated cataract surgery.
P2860
Q34806191-830B39EE-BAFD-484C-B51C-FF996840D976Q35203041-744752E4-3E0E-4262-BAF3-F742FF1E2CCAQ37061080-3BE3EE15-58D4-4519-A5E8-5E7E77A0E3F4Q37063385-4A85E187-5623-4300-BA8A-1E3FF4030F46Q37650784-FBCC6174-70B2-44C1-B189-592FFD03E8AFQ37995532-6D02D942-A986-464B-8F91-F2E7B764509FQ38205005-1556AEA5-6548-409E-AC96-E947A87A8267Q40500729-D673B761-9B08-4561-BE71-C979FFF4BDD1Q41811058-457C3928-0DFC-4AEE-ABEB-F65DDA605A1EQ41873275-28D7110B-5D38-4C18-9DCE-42CE4A8BE1E0Q42411607-3E9459A0-58AA-4A0D-B9C6-279F41187CB4Q46796887-917A6D4F-6053-46E9-B0A4-E336748EB48BQ47602857-985BF399-5916-443F-A76F-768D3C62264FQ53468878-D7BA136D-36AB-4DA1-80CB-E129763AC364
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Ketorolac tromethamine formulations: an overview.
@ast
Ketorolac tromethamine formulations: an overview.
@en
Ketorolac tromethamine formulations: an overview.
@nl
type
label
Ketorolac tromethamine formulations: an overview.
@ast
Ketorolac tromethamine formulations: an overview.
@en
Ketorolac tromethamine formulations: an overview.
@nl
prefLabel
Ketorolac tromethamine formulations: an overview.
@ast
Ketorolac tromethamine formulations: an overview.
@en
Ketorolac tromethamine formulations: an overview.
@nl
P2093
P2860
P1476
Ketorolac tromethamine formulations: an overview.
@en
P2093
P2860
P304
P356
10.1517/17425240903116006
P407
P577
2009-09-01T00:00:00Z